New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

Niagara Falls Exploring Pothole Repair Idea
Advocates Want Formerly Homeless for Committee
Niagara Falls Preps for Ribfest
Hospital Deficits Getting Worse: Report
Man Dies in Lincoln House Fire
Potential Niagara Parks Strike
Man Charged with Possessing Child Porn
Be Wary of Spring Time Scams: NRP